This award accelerates late-stage clinical development of therapeutic and medical device technologies specifically addressing pediatric and rare cancers. It supports breakthrough innovations in cancer treatment, diagnostics, and related technologies to improve outcomes in these underserved areas.
Eligibility criteria are not specified for this funding opportunity.
